Pfizer, Eli Lilly Stock Fall. Questions Remain About Trump’s Executive Order. - Barron's
1. President Trump signed an executive order to lower drug prices. 2. Pharma stocks, including JNJ, declined despite initial optimism. 3. Order directs buybacks at 'most-favored-nation' pricing. 4. High tariffs on pharmaceutical imports remain a threat. 5. Analysts describe the order as 'all bark, little bite.'